Wonder Intensive BBCream 21 (Light)

Manufacturer
DRAN CO.,LTD
Effective date
2017-11-29
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:53:07

Label at a glance#

ProductWonder Intensive BBCream 21 (Light)
Active ingredientTITANIUM DIOXIDE, ZINC OXIDE, DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE, OCTOCRYLENE, OCTINOXATE, OCTISALATE, ADENOSINE, ARBUTIN
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Titanium dioxide, Zinc Oxide, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Octocrylene, Ethylhexyl Methoxycinnamate, Ethylhexyl Salicylate, Adenosine, Arbutin

INACTIVE INGREDIENT SECTION

Water, Butylene Glycol, Allantoin, Etc.

OTC - PURPOSE SECTION

  • Helps prevent sunburn
  • Provides high protection from sunburn
  • Helps keep moisturize

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

  • Use as foundation after basic skin care routine or right afternoon when needed (can use before and after makeup)
  • Apply by pressing the puff into the moistened sponge and patting the puff onto the face

WARNINGS SECTION

1. Do not use in the following cases(Eczema and scalp wounds)

2.Side Effects

1)Due to the use of this product, if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult your pharmacist or doctor

3.General Precautions

1)If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately

2)This product is for exeternal use only. Do not use for internal use

4.Storage and handling precautions

1)If possible, avoid direct sunlight and store in cool and area of low humidity

2)In order to maintain the quality of the product and avoid misuse

3)Avoid placing the product near fire and store out in reach of children

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ll

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70931-0005-12020-01-31C16284748780-19d75b9d0-9ba4-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70931-0005-1Wonder Intensive BBCream 21 (Light)40 g in 1 TUBECREAM403

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70931-0005WONDER INTENSIVE BBCREAM 21 (LIGHT) (TITANIUM DIOXIDE, ZINC OXIDE, DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE, OCTOCRYLENE, ETHYLHEXYL METHOXYCINNAMATE, ETHYLHEXYL SALICYLATE, ADENOSINE, ARBUTIN) CREAM [DRAN CO.,LTD]3Legacy NDC, 1 package rows20171129_3bbc61e1-72c5-6681-e054-00144ff8d46c.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70931-000570931-0005-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
5f1b0b79-6a67-47ae-e053-2991aa0a02ba3bbc61e1-72c5-6681-e054-00144ff8d46c2017-11-29WarningsExact identifier
spl id: 5f1b0b79-6a67-47ae-e053-2991aa0a02ba
spl set id: 3bbc61e1-72c5-6681-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.